Diffuse optical assessment of cerebral-autoregulation in older adults stratified by cerebrovascular risk

Ahmed A Bahrani1,2,3, Weikai Kong1, Yu Shang4

  • 1Department of Biomedical Engineering, University of Kentucky, Lexington, Kentucky, USA.

Insights

Early detection of cerebrovascular disease (CVD) is crucial. This study found that low-frequency oscillation gains, reflecting cerebral autoregulation, differ between high-risk and low-risk groups, suggesting potential as early CVD biomarkers.

Area of Science:

  • Neuroscience
  • Biomedical Engineering
  • Cardiovascular Research

Background:

  • Cerebrovascular disease (CVD) diagnosis is vital for preventing complications.
  • Abnormal cerebral microvasculature in CVD can impair cerebral autoregulation (CA).
  • Early detection methods for CVD are needed.

Purpose of the Study:

  • To investigate low-frequency oscillations (LFOs) of cerebral blood flow (CBF) and hemoglobin concentrations.
  • To assess cerebral autoregulation (CA) dynamics using LFO gains in individuals with varying CVD risk.
  • To determine if LFO gains can serve as early biomarkers for CVD.

Main Methods:

  • A hybrid near-infrared diffuse optical instrument and finger plethysmograph were used.
  • Simultaneous measurement of CBF, [HbO2], [Hb], and mean arterial pressure (MAP) during head-up-tilting (HUT).
  • Transfer function analysis calculated LFO gains (CA ∝ 1/Gain) in low-risk (FRS ≤15) and high-risk (FRS >15) groups.

Main Results:

  • High-risk individuals exhibited lower baseline LFO gains compared to low-risk individuals.
  • Lower baseline gains in the high-risk group may indicate compensatory mechanisms for steady-state CA.
  • Head-up-tilting revealed smaller LFO gain reductions in the high-risk group, suggesting impaired dynamic CA.

Conclusions:

  • LFO gains demonstrate differences between CVD risk groups.
  • Impaired dynamic CA was observed in the high-risk group during HUT.
  • LFO gains show potential as valuable biomarkers for the early detection of CVD.